ORCHARD- Optimising Home Assessment of Rural Patients

Inclusion Criteria: * ● Solid organ transplant recipient * On the COVID-19 shielding list * People with specific cancers * People with cancer who had chemotherapy within the last 2 years * People with lung cancer that have had radical radiotherapy within the last two years * People with cancer of the blood or bone marrow such as leukaemia, lymphoma or myeloma who are at end stage treatment * People that have had immunotherapy or other continuing antibody treatments for cancer within the last two years * People that had other targeted cancer treatment which can affect the immune system, such as protein kinase inhibitors or PARP inhibitors within the last two years * People who had bone marrow or stem cell transplants in the last 6 months, or who are still taking immunosuppression drugs * People with severe respiratory conditions including all cystic fibrosis, severe asthma, and severe COPD * People with rare diseases and inborn errors of metabolism that significantly increase the risk of infections (such as SCID, homozygous sickle cell anaemia) * People in immunosuppression therapies sufficient to significantly increase risk of infection Inclusion criteria for GPs: * A GP working at the pilot study practice and carried out telemedicine consultations with participants * A GP who can provide informed consent Exclusion Criteria: * People whose GP feels they are not able to participate in the research. People unable to consent to participate. Non-English speakers Exclusion criteria for GPs: A GP that cannot provide informed consent